Brief: India Globalization Capital Completes Cohort 1 Of Phase 1 THC-Based Clinical Trial
14/05/2021 11:20
May 14 (Reuters) - India Globalization Capital Inc IGC.A :
* INDIA GLOBALIZATION CAPITAL (IGC) COMPLETES COHORT 1 OF
ITS
PHASE 1 THC-BASED CLINICAL TRIAL ON ALZHEIMER’S PATIENTS
Source text for Eikon: ID:nBw5TpJvja
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment